Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Stem Cell Medicine Licenses Exosome Technology from Ramot at Tel Aviv University

americanpharmaceuticalreviewJanuary 03, 2019

Tag: ASD , Stem Cell Medicine , Intranasal administration , neurological conditions

PharmaSources Customer Service